SERAEX Trademark

Trademark Overview

On Friday, July 26, 2019, a trademark application was filed for SERAEX with the United States Patent and Trademark Office. The USPTO has given the SERAEX trademark a serial number of 79268071. The federal status of this trademark filing is REGISTERED as of Tuesday, May 12, 2020. This trademark is owned by Bühlmann Laboratories AG. The SERAEX trademark is filed in the Medical Instrument Products category with the following description:

Medical diagnostic apparatus for testing blood biomarkers of inflammation and therapeutic drug monitoring, namely, sampling tubes for carrying out chemical, medical and biological analyses for medical diagnosis
seraex

General Information

Serial Number79268071
Word MarkSERAEX
Filing DateFriday, July 26, 2019
Status700 - REGISTERED
Status DateTuesday, May 12, 2020
Registration Number6050345
Registration DateTuesday, May 12, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 25, 2020

Trademark Statements

Goods and ServicesMedical diagnostic apparatus for testing blood biomarkers of inflammation and therapeutic drug monitoring, namely, sampling tubes for carrying out chemical, medical and biological analyses for medical diagnosis

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, October 2, 2019
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBühlmann Laboratories AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressSchönenbuch CH4124
CH
Party NameBühlmann Laboratories AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressSchönenbuch CH4124
CH
Party NameBühlmann Laboratories AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressSchönenbuch CH4124
CH

Trademark Events

Event DateEvent Description
Thursday, September 26, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB
Thursday, October 17, 2019ASSIGNED TO EXAMINER
Thursday, October 24, 2019NON-FINAL ACTION WRITTEN
Wednesday, October 2, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 8, 2019APPLICATION FILING RECEIPT MAILED
Saturday, November 16, 2019REFUSAL PROCESSED BY MPU
Friday, October 25, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, November 16, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, December 6, 2019REFUSAL PROCESSED BY IB
Monday, December 30, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 16, 2020ASSIGNED TO LIE
Tuesday, January 21, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 21, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 21, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 25, 2020PUBLISHED FOR OPPOSITION
Wednesday, February 5, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 5, 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 5, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Saturday, February 22, 2020NOTIFICATION PROCESSED BY IB
Tuesday, February 25, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 12, 2020REGISTERED-PRINCIPAL REGISTER
Thursday, September 17, 2020GENERIC MADRID TRANSACTION CREATED
Thursday, September 17, 2020GENERIC MADRID TRANSACTION SENT TO IB
Wednesday, August 12, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, November 2, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, June 19, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Saturday, June 19, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 12, 2025COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Saturday, June 19, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, June 19, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 30, 2025NEW REPRESENTATIVE AT IB RECEIVED

Related Keywords

seraex medical tubes sampling carrying chemical diagnosis analyses biological namely drug